Impact of MRD status in patients with AML undergoing allogeneic stem cell transplantation in the first vs the second remission

Allogeneic hematopoietic stem cell transplantation (HSCT) offers the best chance for relapse-free survival to most patients with acute myeloid leukemia (AML). It may be performed during complete remission or delayed until after the first relapse because of relevant treatment-related morbidity and mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Jentzsch, Madlen, Bischof, Lara, Backhaus, Donata, Brauer, Dominic, Schulz, Julia, Franke, Georg-Nikolaus, Vucinic, Vladan, Niederwieser, Dietger, Platzbecker, Uwe, Schwind, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636320/
https://www.ncbi.nlm.nih.gov/pubmed/35605254
http://dx.doi.org/10.1182/bloodadvances.2022007168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636320/
https://www.ncbi.nlm.nih.gov/pubmed/35605254
http://dx.doi.org/10.1182/bloodadvances.2022007168

Ejemplares similares